In India. the production, sale, purchase, possession, transport and use of cannabis is prohibited under Narcotics Drugs and Psychotropic substances (NDPS) Act of 1985. The major psychoactive constituent in cannabis is Delta-9 tetrahydrocannabinol (THC). Those recommendations outlined protocol for internationally regulating the medical use of different parts of the plant, including cannabis as a whole, cannabidiol (CBD) and tetrahydrocannabinol (THC). The WHO recommended that cannabis still be listed there, noting "the high rates of public health problems arising from cannabis use".
Regulatory Affairs Specialist, Lina Lozano says, "New Zealand is ahead of the curve, with the introduction the Medicinal Cannabis scheme in April this year".
Confirming something most of us already know, the United Nations has removed cannabis from its list of the world's most risky drugs. "However, this reform alone is far from adequate given that cannabis remains incorrectly scheduled at the global level". This UN vote may encourage other countries to adopt similar legislation that could create future export opportunities for New Zealand medicinal cannabis products. Some of the medical benefits of marijuana listed in the WHO's recommendation included reducing pain and nausea, easing symptoms of conditions including anorexia, epilepsy and multiple sclerosis. The proposals were to be placed before the CND's session in March that year, but members overwhelmingly voted to postpone the vote, requesting additional time. However, regulation of the substance will more or less depend upon the individual countries. However, both substances will continue to remain on Schedule I, the least unsafe category.
"What's quite shocking really is that a number of countries that do allow medicinal cannabis at home still voted against this decision in the UN."
The U.S. voted for the cannabis reclassification-a move that could signify the country's interest in moving toward cannabis decriminalization or all-out legalization.